Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752842 · ClinicalTrials.gov registry record · NA
Lipid Biomarkers for Diabetic Heart Disease
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01752842: Completed NA study, sponsored by Washington University School of Medicine.
NCT01752842 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01752842, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
Primary Outcome
Change was measured by echocardiography and was calculated as the value at 12 weeks minus the value at baseline.
Interventions
- DRUG Fenofibrate
- DRUG Placebo for fenofibrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-02-23 |
| Phase | NA |
What the finished NCT01752842 record still lists
NCT01752842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Fenofibrate is the first listed.
NCT01752842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01752842 about?
NCT01752842 is a clinical study titled "Lipid Biomarkers for Diabetic Heart Disease". This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
What is the current status of trial NCT01752842?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-03. Estimated completion is 2018-02-23.
What interventions are being tested in trial NCT01752842?
The interventions under investigation include: Fenofibrate (DRUG), Placebo for fenofibrate (DRUG).
Who is sponsoring clinical trial NCT01752842?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01752842's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia